Unlocking the financing potential of forest-based carbon assets: a valuation framework for pledge lending under uncertainty in China. [PDF]
Zhang Y, Zhang J.
europepmc +1 more source
Cost-effectiveness of first-line osimertinib plus chemotherapy versus amivantamab plus lazertinib for advanced EGFR-mutant NSCLC in the US and China. [PDF]
Guo Y +11 more
europepmc +1 more source
The cost-effectiveness of biosimilar denosumab in postmenopausal osteoporosis: implications of baseline fracture risk and drug price. [PDF]
Li E +5 more
europepmc +1 more source
Variance and volatility swap valuation with nonlinear liquidity-feedback stochastic volatility and regime switching. [PDF]
Fu J, Wang K.
europepmc +1 more source
Valuation of Medical Innovation in Orphan Diseases with a Focus on Small Investors and Limited Diversifiable Risks. [PDF]
Nuijten M, Gelder PV.
europepmc +1 more source
Lack of online price transparency of small animal veterinary clinics in the United States. [PDF]
Adams A +3 more
europepmc +1 more source
Agentic AI systems in electrical power systems engineering: current state-of-the-art and challenges. [PDF]
Ghosh S, Mittal G.
europepmc +1 more source
The Multiple Criteria Qualitative Value-Based Pricing Framework "MARIE" for Novel Cell and Gene Therapy. [PDF]
Takami A, Igarashi A.
europepmc +1 more source
Medicaid access to Most Favored Nation through the Pfizer agreement: The unanswered issues. [PDF]
Ballreich J +4 more
europepmc +1 more source

